Safety and impact of the Mediterranean diet in patients with chronic kidney disease: a pilot randomized crossover

Yu-Jin Kwon1, Young Su Joo2, Hae-Ryong Yun2

  • 1Department of Family Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea.

Frontiers in Nutrition
|September 19, 2024
PubMed
Abstract

Insights

The Mediterranean Proper Optimal Balance (MEDi-POB) diet is safe for Korean patients with chronic kidney disease (CKD). This diet helps maintain kidney function and manage metabolic acidosis without negatively impacting potassium levels.

Area of Science:

  • Nephrology
  • Nutritional Science
  • Clinical Nutrition

Background:

  • The Mediterranean diet (MD) shows promise in preserving kidney function and slowing chronic kidney disease (CKD) progression.
  • Interventional studies on the MD are limited in East Asian populations, necessitating research in this demographic.

Purpose of the Study:

  • To evaluate the safety and short-term effects of the Mediterranean Proper Optimal Balance (MEDi-POB) diet.
  • To assess the impact of the MEDi-POB diet on kidney function in Korean patients with stage 3-4 CKD.

Main Methods:

  • A randomized crossover trial involving 50 Korean patients with stage 3-4 CKD.
  • Participants underwent two 4-week intervention periods: MEDi-POB diet with home-delivered meals or a conventional control diet, separated by a 4-week washout period.
  • Kidney function was assessed via estimated glomerular filtration rate (eGFR); dietary intake and metabolic markers were also analyzed.

Main Results:

  • The MEDi-POB diet significantly increased intake of fat, fiber, and niacin, while decreasing sodium and copper intake.
  • Patients on the MEDi-POB diet showed improved management of metabolic acidosis (increased CO2 levels) and a slight decrease in body mass index.
  • Kidney function (eGFR) was well-preserved, and serum and urine potassium levels remained stable, indicating safety.

Conclusions:

  • The MEDi-POB diet is safe for Korean patients with advanced CKD (stage 3-4).
  • This dietary intervention effectively maintains kidney function and aids in managing metabolic acidosis.
  • The MEDi-POB diet does not adversely affect potassium homeostasis in CKD patients.

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
61
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
68
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
349
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
276
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
396
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
323